Two-center clinical study on the effect of chronic renal impairment on safety of iopromide 300 mg iodine/ml.
Clinical Development Diagnostics, Schering AG, Berlin, Germany.
C
C
Harz
E M
EM
Fallenberg
R
R
Schäfer
A
A
Magnusson
W
W
Clauss
W
W
Heindel
B
B
Tombach
D003287:Contrast Media / Q000009:adverse effects*; D003404:Creatinine / Q000032:analysis; D006801:Humans; D007472:Iohexol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D010808:Physical Examination; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D003404:Creatinine